Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increaseMaitreyee K. Jathal, P. Ghosh|British Journal of Cancer|2019Cited by 23
Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinaseMaitreyee K. Jathal, P. Ghosh|Journal of Biological Chemistry|2023Cited by 7
Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular LocalizationMaitreyee K. Jathal, P. Ghosh|Research Square|2024Cited by 0